Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Ascelia Pharma AB

Closing information (x1000 SEK)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 2,418 More Arrow 3,965 Less Arrow 2,014
Earnings before taxes -109,607 Less Arrow -133,155 More Arrow -129,523
EBITDA -109,865 Less Arrow -145,961 More Arrow -136,918
Total assets 87,072 More Arrow 218,569 More Arrow 333,493
Current assets 28,937 More Arrow 160,869 More Arrow 274,611
Current liabilities 12,568 More Arrow 37,517 Less Arrow 25,106
Equity capital 74,328 More Arrow 180,859 More Arrow 307,834
- share capital 34,871 Equal arrow 34,871 Less Arrow 34,576
Employees (average) 23 Less Arrow 22 Less Arrow 20

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 85.4% Less Arrow 82.7% More Arrow 92.3%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -123.1% More Arrow -59.1% More Arrow -38.2%
Current ratio 230.2% More Arrow 428.8% More Arrow 1093.8%
Return on equity (ROE) -147.5% More Arrow -73.6% More Arrow -42.1%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 1 More Arrow 2 More Arrow 9
Chg. No. of employees % 5% More Arrow 10% More Arrow 82%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.